Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Cancer Immunology Research|January 6, 2019
SUV39H1 Represses the Expression of Cytotoxic T-Lymphocyte Effector Genes to Promote Colon Tumor Immune EvasionChunwan Lu, Dafeng Yang, John D Klement, et al.
Cancers|February 27, 2026
A Novel Mouse Model to Identify Antigen-Specific Immune Responses in Pancreatic Cancer CachexiaAyushi Das, Debasmita Mukherjee, Liliana D'Alesio, et al.
Carcinogenesis|February 25, 2016
Integrin-linked kinase as a novel molecular switch of the IL-6-NF-κB signaling loop in breast cancerEn-Chi Hsu, Samuel K Kulp, Han-Li Huang, et al.
JCSM Rapid Communications|September 13, 2021
Murine cancer cachexia models replicate elevated catabolic pembrolizumab clearance in humansAlyssa Marie M Castillo, Trang T Vu, Sophia G Liva, et al.
Frontiers in Immunology|April 16, 2026
Fc gamma receptor binding modulates IgG clearance in cancer cachexiaBryan C Remaily, Kyeongmin Kim, Justin Thomas, et al.
Pharmacological Research|December 25, 2023
Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexiaTrang T Vu, Kyeongmin Kim, Millennium Manna, et al.
International Immunopharmacology|May 8, 2026
FcRn function alone cannot account for elevated IgG clearance in the Lewis lung carcinoma model of cancer cachexiaAdeoluwa Adeluola, Justin Thomas, Bryan Remaily, et al.
International Journal of Molecular Sciences|July 9, 2022
The Neonatal Fc Receptor Is Elevated in Monocyte-Derived Immune Cells in Pancreatic CancerJustin Thomas, Molly A Torok, Kriti Agrawal, et al.
Plos One|June 10, 2010
The novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-cell malignancies in vitro and in vivoDavid M Lucas, Lapo Alinari, Derek A West, et al.
Clinical Lung Cancer|February 8, 2022
Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not ChemoimmunotherapyYizhen Guo, Lai Wei, Sandip H Patel, et al.
Pageof 14